Effects of various pre-analytical conditions on blood-based biomarkers of Alzheimer's disease

Clin Chem Lab Med. 2021 Jul 7;59(12):e435-e437. doi: 10.1515/cclm-2021-0637. Print 2021 Nov 25.
No abstract available

Keywords: Alzheimer’s disease; Tau; amyloid β; blood collection; plasma biomarker; pre-analytic conditions.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alzheimer Disease* / diagnosis
  • Amyloid beta-Peptides
  • Biomarkers
  • Humans
  • Peptide Fragments
  • tau Proteins

Substances

  • Amyloid beta-Peptides
  • Biomarkers
  • Peptide Fragments
  • tau Proteins